Pfizer Inc. — Patent Applications
Recent USPTO patent applications filed under applicant “Pfizer Inc. / PFIZER INC.” — pending requests, not granted patents. Where a filing continues an already-granted parent, the parent’s number is shown.
Recent Applications
Every row is a patent application — a pending request, not a granted patent. “Granted Parent” shows the parent patent number when a filing continues an already-granted family. Newest filings first. Source: USPTO Open Data Portal (public).
| Title | Filed | Application # | Status | Granted Parent |
|---|---|---|---|---|
| HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS | 2025-12-29 | 19434867 | Docketed New Case - Ready for Examination | parent 11964961 |
| METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2025-12-19 | 19426894 | Docketed New Case - Ready for Examination | — |
| IMMUNOGENIC COMPOSITIONS AND USES THEREOF | 2025-12-17 | 19423280 | Application Undergoing Preexam Processing | parent 12527855 |
| Biaryl Acid Compounds | 2025-11-14 | 19389226 | Docketed New Case - Ready for Examination | — |
| ANTI-TL1A ANTIBODY THERAPEUTIC METHODS | 2025-11-14 | 19390127 | Application Undergoing Preexam Processing | — |
| Biaryl Acid Compounds | 2025-11-03 | 63910617 | Application Dispatched from Preexam, Not Yet Docketed | — |
| THERAPEUTIC ANTIBODIES AND THEIR USES | 2025-10-31 | 19376744 | Docketed New Case - Ready for Examination | parent 9969809 |
| TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF | 2025-10-28 | 19371574 | Docketed New Case - Ready for Examination | parent 10550200 |
| LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | 2025-10-23 | 19366670 | Docketed New Case - Ready for Examination | — |
| VARENICLINE FORMULATIONS | 2025-10-17 | 19476433 | Docketed New Case - Ready for Examination | — |
| EXTENDED RELEASE FORMULATIONS COMPRISING SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF | 2025-10-03 | 19348897 | Docketed New Case - Ready for Examination | — |
| KAT6A AS A PREDICTIVE BIOMARKER FOR TREATMENT OF BREAST CANCER WITH A CDK4 INHIBITOR AND AN ANTIESTROGEN AND METHODS OF TREATMENT THEREOF | 2025-09-29 | 19470726 | Application Undergoing Preexam Processing | — |
| COMPOSITIONS AND METHODS FOR REDUCTION OF DOUBLE-STRANDED RNA | 2025-09-25 | PCTUS2025047904 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | 2025-09-23 | 63886202 | Application Dispatched from Preexam, Not Yet Docketed | — |
| MEDIA AND FERMENTATION METHODS FOR PRODUCING POLYSACCHARIDES IN BACTERIAL CELL CULTURE | 2025-09-16 | 19330622 | Docketed New Case - Ready for Examination | parent 10947494 |
| Modulating the Innate Immunity of RNA | 2025-09-15 | 19165220 | Sent to Classification contractor | — |
| HYBRID SENSOR NETWORK IN AUTOCLAVING OF PRE-FILLED VIALS | 2025-09-09 | 19323050 | Docketed New Case - Ready for Examination | — |
| SYSTEMS AND METHODS FOR ANNEALING FROZEN BULK IN DYNAMIC BULK FREEZE DRYING | 2025-09-02 | 19161386 | Application Undergoing Preexam Processing | — |
| SYSTEMS AND METHODS FOR PRE-CONDITIONING FROZEN BULK IN DYNAMIC BULK FREEZE DRYING | 2025-09-02 | 19161341 | Application Undergoing Preexam Processing | — |
| GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF | 2025-08-20 | 19304775 | Docketed New Case - Ready for Examination | — |
| HEALTH INFORMATION NETWORK WELLNESS PLATFORM | 2025-08-08 | PCTUS2025041354 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| HEALTH INFORMATION NETWORK WELLNESS PLATFORM | 2025-08-08 | 19295245 | Non Final Action Mailed | — |
| Biphenyl and Phenylpyridine Compounds | 2025-07-31 | 19286812 | Patented Case | — |
| METHODS FOR TREATMENT OF ATOPIC DERMATITIS WITH AN ANTI-TL1A ANTIBODY | 2025-07-30 | 63854087 | Application Dispatched from Preexam, Not Yet Docketed | — |
| RNA MOLECULES | 2025-07-29 | PCTUS2025039598 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| COMBINATION THERAPY USING CDK4 INHIBITORS FOR CANCER TREATMENTS | 2025-07-25 | PCTUS2025039221 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| GLP-1 Receptor Agonists and Uses Thereof | 2025-07-16 | 19271268 | Docketed New Case - Ready for Examination | parent 12378230 |
| IMMUNOGENIC COMPOSITIONS AND USES THEREOF | 2025-07-16 | 19270518 | Docketed New Case - Ready for Examination | — |
| RNA Molecules | 2025-07-14 | 63843401 | Application Dispatched from Preexam, Not Yet Docketed | — |
| IMMUNOGENIC COMPOSITIONS AND USES THEREOF | 2025-07-10 | 63841690 | Application Dispatched from Preexam, Not Yet Docketed | — |
| IMMUNOGENIC COMPOSITIONS AND METHODS OF INDUCING AN IMMUNE RESPONSE AGAINST VARICELLA ZOSTER VIRUS | 2025-07-09 | 19146827 | Docketed New Case - Ready for Examination | — |
| GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF | 2025-07-04 | 63838788 | Application Dispatched from Preexam, Not Yet Docketed | — |
| NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF | 2025-07-02 | 19257652 | Docketed New Case - Ready for Examination | parent 12383611 |
| COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE | 2025-06-23 | 19245575 | Abandoned -- Incomplete Application (Pre-examination) | — |
| LIPID PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF | 2025-06-20 | 19141635 | Application Undergoing Preexam Processing | — |
| RSV F Protein Mutants | 2025-06-18 | 19242479 | Docketed New Case - Ready for Examination | parent 12364749 |
| E. COLI FIMH MUTANTS AND USES THEREOF | 2025-06-18 | 19241786 | Docketed New Case - Ready for Examination | parent 12357681 |
| IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF | 2025-06-17 | 19240698 | Docketed New Case - Ready for Examination | parent 11020469 |
| IMMUNOGENIC COMPOSITIONS AND USES THEREOF | 2025-06-10 | 63821157 | Application Dispatched from Preexam, Not Yet Docketed | — |
| METHOD OF TREATING BREAST CANCER | 2025-05-30 | 19134632 | Application Undergoing Preexam Processing | — |
| PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | 2025-05-28 | 19133544 | Docketed New Case - Ready for Examination | — |
| THERAPEUTIC USE OF GDF15 ANTIBODIES | 2025-05-21 | PCTUS2025030336 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| Methods for Preparing Conjugated Capsular Saccharide Antigens and Uses Thereof | 2025-05-20 | 19131515 | Application Undergoing Preexam Processing | — |
| HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS | 2025-05-20 | 19213586 | Abandoned -- Incomplete Application (Pre-examination) | parent 11964961 |
| METHODS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH AN ANTI-TL1A ANTIBODY | 2025-05-16 | 19210817 | Docketed New Case - Ready for Examination | — |
| GLP-1 Receptor Agonists and Uses Thereof | 2025-05-15 | 19209381 | Docketed New Case - Ready for Examination | parent 12331041 |
| Substituted Bicyclic Pyridone Derivatives | 2025-05-14 | 19129777 | Docketed New Case - Ready for Examination | — |
| AUTOMATED SELF-OPTIMIZATION OF CONTINUOUS CRYSTALLIZATION | 2025-05-05 | 19127264 | Docketed New Case - Ready for Examination | — |
| Therapeutic Use of GDF15 Antibodies | 2025-05-05 | 63799998 | Provisional Application Expired | — |
| METHOD AND SYSTEM OF SIMULATING OPERATIONAL INTEGRITY OF A PRE-FILLED VIAL | 2025-05-02 | 19196932 | Docketed New Case - Ready for Examination | — |
How to read this
Every row here is an application — a request the USPTO has not yet decided. In plain English: these filings show where Pfizer Inc.’s R&D effort is pointed right now, often 18–24 months before any product ships — but an application can be amended, abandoned, or rejected, and most confer no enforceable rights until granted. A “granted parent” tag means the filing continues a patent family that already has a grant — the new claims themselves are still pending. Filings are matched by applicant name, so work filed under subsidiary or research-entity names may not appear. Source: USPTO Open Data Portal (public).
How many patent applications does Pfizer Inc. have on file?
Oxford Ledge tracks 50 U.S. patent applications for Pfizer Inc., of which 12 continue an already-granted patent family. Every row is an application (a pending request to the USPTO), not a granted patent.
What is the difference between a patent application and a granted patent?
A patent application is a pending request filed with the USPTO; a granted patent is one the USPTO has examined and issued. These pages track applications, which signal a company's R&D direction before any patent is granted.
Where does this patent data come from?
The USPTO Open Data Portal (public), matched to the company's applicant registrations.